This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Iovance Biotherapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Weiser: Innovator in T-Cell Coculture Potency Assays
Introduction
Michael Weiser is a notable inventor based in Miami, FL (US). He has made significant contributions to the field of cell therapy through his innovative work. With a total of 2 patents, Weiser is recognized for his advancements in T-cell coculture potency assays.
Latest Patents
Weiser's latest patents include "Methods and Compositions for T-Cell Coculture Potency Assays and Use with Cell Therapy Products." This invention focuses on enhancing the effectiveness of cell therapy products by improving the assessment of T-cell potency.
Career Highlights
Michael Weiser is currently employed at Iovance Biotherapeutics, Inc., where he continues to push the boundaries of research in cell therapy. His work is instrumental in developing innovative solutions that can potentially transform patient care.
Collaborations
Weiser collaborates with esteemed colleagues, including Michelle R. Simpson-Abelson and Matthew J. Frigault. Together, they contribute to advancing the field of immunotherapy and cell-based treatments.
Conclusion
Michael Weiser's contributions to T-cell coculture potency assays highlight his role as a key innovator in the field of cell therapy. His work at Iovance Biotherapeutics, Inc. and his collaborations with other experts underscore the importance of teamwork in driving scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile